image credit: Paul Sableman / Flickr

CVS Health earnings top estimates as prescription volume, Covid vaccines increase

February 16, 2021


CVS Health’s fourth-quarter earnings beat Wall Street’s expectations Tuesday as prescription volume lifted sales and the drugstore chain attracted new customers with Covid-19 testing and vaccines.

Shares of the company were down more than 4% early Tuesday.

Here’s what the company reported for the fiscal fourth quarter ended Dec. 31, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.30 adjusted vs. $1.24 expected
  • Revenue: $69.55 billion vs. $68.75 billion expected

Read More on CNBC